Wrist sensor system to increase use of the weak arm at home after stroke
Official title: A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life of Chronic Stroke Survivors
Run by Spaulding Rehabilitation Hospital · NCT05626894 · Data updated 2026-11-12
This program will test whether wearing the StrokeWear wrist sensor combined with a motor and behavioral home program helps chronic stroke survivors with hemiparesis use their affected arm more than a standard home-exercise plan.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | Spaulding Rehabilitation Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | March 20, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | November 28, 2025 |
| Trial ID | NCT05626894 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–85 with unilateral upper-extremity hemiparesis from an anterior circulation ischemic stroke 6 months to 5 years earlier, FMA-UE scores between 20 and 45, intact cognition (MMSE >23 and able to follow commands), and comfortable using a smartphone or tablet.
✕Probably not a fit
Patients with severe spasticity (Modified Ashworth Scale ≥3), significant visual field loss or hemispatial neglect, or notable cognitive impairment are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a two-arm randomized Phase 2 trial lasting six months comparing the StrokeWear system plus a motor and behavioral home intervention against a usual-care home exercise plan. Participants will have outcome evaluations at baseline, 3 months, and 6 months, and groups are stratified by baseline motor impairment and stroke chronicity. The intervention arm receives frequent coaching (weekly in month 1, bi-weekly in months 2–3, monthly in months 4–6) delivered in person or remotely, while the control arm receives monthly visits to update their home-exercise plan. Upper-extremity motor function will be measured across ICF domains (including FMA-UE) and participants must be able to use a tablet or smartphone and have intact cognition.
Why it matters
Potential benefit: If successful, this approach could increase everyday use of the impaired arm and improve functional independence for chronic stroke survivors.
How similar studies have gone: Previous small studies and pilot programs using wearable sensors and behaviorally guided home rehabilitation have shown promising signals for increasing arm use, but large randomized phase 2 evidence is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, 18-85 years of age at the time of enrollment; * Anterior circulation ischemic stroke at least 6 months and up to 5 years prior to study enrollment; * Unilateral upper extremity hemiparesis as characterized by initial scores on upper limb subtest of the Fugl-Meyer Assessment (FMA-UE) between 20 and 45; * Intact cognitive function to understand the study procedures and goal setting (MMSE score above 23 and able to follow 3 step command); * Being familiar and comfortable with the use of a tablet or smartphone. Exclusion Criteria: * Severe spasticity (defined as a Modified Ashworth scale score of 3 or more) that would prevent safe performance of UE tasks; * Visual impairments as assessed by the NIH Stroke Scale Visual Field subscale (only subjects with no visual loss will participate in the study); or hemispatial neglect that would impair the subject ability to see feedback on the app screen (as assessed with the star cancellation test); * Individuals with open wounds or recent fracture (less than 3 months) in the UE, fragile skin or active infection as evaluated by the study therapist; * Individuals currently enrolled in a UE rehabilitation program (i.e., OT, research study) * Upper-extremity orthopedic injuries or severe pain resulting in movement limitations; * Diagnosis of other neurological disease (i.e., Parkinson's disease, multiple sclerosis, ...); * Severe proprioceptive deficits that impair the ability to process the vibration feedback, as assessed by physical examination during screening as assessed by the study therapist; * Not understanding spoken or written English; * Recent (less than 3 months) Botox injection in the UE or plan to undergo injections during the study timeline; * Contralateral motor deficits as assessed by clinical examination; * Brainstem and cerebellar stroke.
Where it's running
-
Spaulding Rehabilitation Hospital Boston
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Paolo Bonato, PhD — Spaulding Rehabilitation Hospital
- Study coordinator: Paolo Bonato, PhD
- Email: pbonato@partners.org
- Phone: 617-952-6319
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wrist-worn device to encourage use of the weaker arm after a recent stroke
This trial tests whether a wrist-worn sensor system plus motor and behavioral home coaching helps people 1–6 months after a stroke with moderate arm weakness use their affected arm more than a usual home-exercise program.
-
Using the Atalante exoskeleton to help stroke patients walk again
This study is testing if using the Atalante exoskeleton can help stroke patients walk better compared to regular therapy.
-
Quadriceps muscle activity and gait in people after stroke with stiff-knee gait vs healthy controls
We will test whether quadriceps muscle activity and walking movement differ between adults with post-stroke stiff-knee gait and healthy adults.
-
Home-based vs. in-clinic upper extremity rehabilitation after stroke
This study tests whether a 20-hour home telerehabilitation program (tele-CPASS) works as well as the same in-clinic CPASS therapy for improving arm and hand function after stroke.
-
Repetitive transcranial magnetic stimulation to improve heart-autonomic function after stroke
This test adds rTMS to usual neurological rehabilitation to see if it improves heart rate variability, autonomic symptoms, arm strength, and quality of life in people at least three months after a stroke.
-
Spatial StimelMD for upper-limb recovery after stroke or traumatic brain injury
This trial will test whether adding the Spatial StimelMD device to standard rehabilitation helps adults with upper-limb weakness after stroke or traumatic brain injury improve arm movement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.